Circa Group AS

Circa Group AS Equity

Delisted

The The Equity of Circa Group AS (CIRCA.OL) as of Oct 23, 2026 is 30.06 M EUR. In the previous year, The Equity was 36.03 M EUR — a change of -16.57% (lower).

Equity

30.06 MEUR

YoY

-16.57%

Last updated:

In 2023, Circa Group AS's equity was 30.06 M EUR, a -16.57% increase from the 36.03 M EUR equity in the previous year.

The Circa Group AS Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2020
-349,900.00 EUR
Jan 1, 2021
41.74 M EUR
Jan 1, 2022
36.03 M EUR
Jan 1, 2023
30.06 M EUR
The Circa Group AS Equity history
YEAREquityYoY
30.06 MEUR-16.57%
36.03 MEUR-13.69%
41.74 MEUR-12,029.69%
-349,900.00EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Circa Group AS Stock analysis

What does Circa Group AS do? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Circa Group AS's Equity

Circa Group AS's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Circa Group AS's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Circa Group AS's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Circa Group AS's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Circa Group AS’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Circa Group AS stock

The Equity of Circa Group AS is 30.06 M EUR in 2023.

The Equity of Circa Group AS changed from 36.03 M EUR to 30.06 M EUR, representing a -16.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Circa Group AS since 2006 – with annual values, charts, and detailed analysis.

The Equity's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Circa Group AS historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Circa Group AS

All Key Metrics — Circa Group AS